Review status: This evidence rewrite has been editorially updated and is not medically reviewed. Qualified expert review is still pending. An ophthalmologist or optometrist has not reviewed the eye and drug claims, and a cosmetic toxicology expert has not reviewed the ingredient-safety wording.
Plain answer: A lash serum label tells you what is in the tube. It does not prove that one part grows lashes. It also cannot prove the serum is safe for every person. First, copy the exact ingredient name. Then ask two things: Does it work? What does a safety source say? We call these effectiveness evidence and safety status.
Key Takeaways
- Copy the exact INCI name. A name fragment is not enough to classify every ingredient.
- Match the source to the claim. A drug label, human formula study, laboratory test, and ingredient database answer different questions.
- Keep effectiveness and safety separate. Stronger growth evidence does not mean lower risk.
- Do not estimate dose from list position. Most cosmetic labels do not state each ingredient's concentration.
- Effectiveness evidence
- The type and quality of research behind a growth claim.
- Safety status
- What a named authority or source says about an exact ingredient, formula, use, and jurisdiction.
- Not assessed
- We did not find enough source material to make a safety assessment. It does not mean safe or unsafe.
The Lash List editorial grade key: A = strong controlled human evidence for the exact use. B = one controlled human study. C = a small uncontrolled human formula study. D = laboratory, animal, scalp-hair, or supplier evidence. E = label presence, theory, or no direct human eyelash evidence. This is our editorial rubric, not a recognized clinical grading system. Grades do not rate safety.
"As a trichologist, I believe consumers deserve greater transparency when choosing lash serums, particularly those containing prostaglandin analogues. While these ingredients may support lash growth, they can also influence follicular behavior and may carry side effects that many consumers are unaware of. Resources that help break down ingredient profiles and compare products objectively can play an important role in helping individuals make informed decisions about products used around such a sensitive area."
Evidence boundary: This is an expert perspective, not proof that every prostaglandin analogue has the same effect or side-effect rate. Check the source for the exact ingredient and product below.
Which Lash Serum Ingredients Matter Most?
Plain answer: Start with five topics. They are prostaglandin analogues, isopropyl cloprostenate, bimatoprost, peptides, and Myristoyl Pentapeptide-17. They do not have the same proof. Bimatoprost is a prescription drug with an approved use for sparse lashes. Cosmetic analogues have different safety reviews. Peptide claims need a source for the exact ingredient or formula.
| Topic | Evidence question | Safety question |
|---|---|---|
| Prostaglandin analogues | Which exact chemical and use were studied? | Which authority assessed it, where, and for what use? |
| Isopropyl cloprostenate | Do not transfer bimatoprost results to this ingredient. | Read the 2026 SCCS opinion and current Canada status. |
| Bimatoprost | The prescription label supports an exact drug, dose, route, and indication. | Use the current drug label, not a class-wide safety guess. |
| Peptides | Finished-formula evidence cannot prove every peptide works. | Safety depends on the exact ingredient, amount, formula, and user. |
| Myristoyl Pentapeptide-17 | Direct human eyelash evidence for the ingredient alone is not established here. | Do not infer whole-formula safety from one ingredient name. |
Lash Serum Label Checklist
Copy the full label, keep the formula date, verify exact ingredient names, and mark any claim that lacks a source for the finished product or ingredient studied.
How We Handle Evidence
We give the most weight to current regulator and drug-label sources, then relevant human studies and systematic reviews. A laboratory result, supplier test, scalp-hair study, or ingredient database cannot prove human eyelash growth. Read our editorial methodology and disclosure policy.
Jump to a section:
- What is the main ingredient in lash serums?
- What are the best ingredients for eyelash growth?
- How to read a lash serum label
- Effectiveness evidence and safety status
- Ingredients to avoid (separate guide)
What Is the Main Ingredient in Lash Serums?
Plain answer: There is no one main ingredient in every lash serum. Some use a prostaglandin analogue. Others use peptides, plant extracts, or conditioners. These groups do not have the same proof. Bimatoprost has prescription eyelash evidence. Cosmetic analogues and peptides need their own checks. Read the exact name, not just the front label.
Prostaglandin analogues are a chemical family. One member, bimatoprost, appears in the prescription drug Latisse. The current DailyMed label says Latisse treats eyelash hypotrichosis by increasing lash growth, including length, thickness, and darkness. That finding applies to the labeled drug and use. It does not prove that another analogue or cosmetic peptide works the same way.
In February 2026, the EU Scientific Committee on Consumer Safety assessed isopropyl cloprostenate, Methylamido Dihydro Noralfaprostal (MDN), and Dechloro Dihydroxy Difluoro Ethylcloprostenolamide (DDDE). The SCCS opinion concluded that none of the three could be considered safe for the intended cosmetic use to support eyelash or eyebrow growth. This is an SCCS scientific opinion. It is not, by itself, an EU-wide legal ban.
Canada's Cosmetic Ingredient Hotlist, checked July 11, 2026, lists prostaglandins, their salts, derivatives, and analogues as prohibited in cosmetics. The entry specifically includes isopropyl cloprostenate. That is a Canadian regulatory status and should not be presented as a worldwide rule.
Three groups need three different evidence checks
The ingredient name alone does not tell you how strong the evidence is.
Do not transfer one drug's results or warnings to every member of the family.
A result for one formula cannot prove that every peptide caused the result.
Conditioning is not the same claim as making new lashes grow.
A bounded name list, not a universal spotting rule
This hub currently covers bimatoprost, isopropyl cloprostenate, MDN, and DDDE. That list is versioned July 11, 2026. A word fragment such as “prost” may help you start a search, but it cannot classify every ingredient. Verify the complete INCI name against a current authority source.
What Are the Best Ingredients for Eyelash Growth?
Plain answer: “Best” depends on your question. Bimatoprost has the strongest proof for a prescription lash use. Peptides are common in cosmetics. But formal lash research is limited. Plant extracts and conditioners can have a cosmetic job. This does not prove they change how human eyelashes grow.
A 2024 comprehensive review found promising signals for non-prostaglandin options but limited formal evidence for eyelash serums. This means a peptide or botanical claim needs careful source labeling. Scalp-hair research, laboratory work, and supplier data may help explain a theory. They do not prove that an ingredient grows human eyelashes.
A 30-person open-label study reported results for one multi-ingredient lash serum. It had no untreated control group. Because the formula contained several ingredients, the study cannot show that one peptide caused the result. It also cannot show that peptide formulas are equal to bimatoprost.
Myristoyl Pentapeptide-17 is used in cosmetic lash formulas. Direct human eyelash evidence for that ingredient alone is not established in the sources reviewed for this hub. Laboratory keratin findings are not clinical proof of longer or fuller human eyelashes.
A 2025 Danish EPA-commissioned report measured Myristoyl Pentapeptide-17, Biotinoyl Tripeptide-1, and Acetyl Tetrapeptide-3 in 19 serums bought in Denmark and the EU. It found no health concern for those three peptides under the project's exposure assumptions. It also found no direct toxicology data for the peptide ingredients. This is useful safety evidence, not a class-wide clearance or proof of growth.
Panthenol and biotin can have cosmetic functions. The CIR panthenol assessment and CIR biotin assessment support conclusions under the uses and concentrations assessed. They do not prove that either ingredient grows new eyelashes. A CIR conclusion for one ingredient also does not establish the safety of a whole eye-area formula.
Looking for what to avoid?
Use the dedicated guide for action-focused ingredient checks. Product formulas can change, so match every classification to a dated ingredient label.
How to Read a Lash Serum Ingredient Label
Plain answer: Copy the full ingredient list. Keep the date and country where you found it. Search the exact INCI name. Then ask what kind of proof supports each claim. Label order can offer clues about a formula, but it does not reveal the exact dose. Never call an unknown ingredient safe just because it is missing from a checker.
Read the label in five steps
Keep the name, source, formula, safety, and date tied together.
Copy every letter of the INCI name.
Drug label, human study, lab test, or database?
A blend study cannot isolate one ingredient.
Record the ingredient, use, authority, and country.
Labels and regulator lists can change.
- Do not use list position as a dose. The label usually does not give the concentration of each ingredient. Position alone cannot prove that an amount is effective.
- Do not use preservative position as a cutoff. An active listed after a preservative is not automatically too weak to work.
- Do not make phenoxyethanol a position rule. Its place on a list cannot prove that the formula lacks enough active ingredient.
- Do not call every botanical or peptide a growth active. Look for direct human eyelash evidence before saying it changes the lash cycle.
- Do not treat a database entry as approval. The European Commission CosIng notice says inclusion does not mean an ingredient is approved for use.
The FDA explains that cosmetics generally do not receive premarket approval, except for color additives. A product claim about treating a condition or affecting body structure or function may place it in drug territory. “FDA approved” should therefore be checked against an exact product and indication, not assumed from a cosmetic ingredient list.
Effectiveness Evidence and Safety Status
These columns answer different questions. Effectiveness evidence asks whether an exact ingredient or formula changed human eyelashes. Safety status records what a named source concluded for a stated use. It is not a universal score.
| Ingredient or group | Effectiveness evidence | Main limit | Source-bounded safety status |
|---|---|---|---|
| Bimatoprost | Strong for the exact prescription eyelash indication in the current drug label | Cannot be transferred to cosmetic peptides or other analogues | Use the current DailyMed warnings and adverse reactions for the labeled drug |
| Isopropyl cloprostenate, MDN, and DDDE | No approved eyelash indication established here | Bimatoprost evidence does not prove these ingredients work | The 2026 SCCS opinion says they could not be considered safe for the intended cosmetic lash and brow use |
| Peptides | Limited formal evidence; some finished-formula studies exist | A blend study cannot isolate a peptide or show class-wide equivalence | A 2025 Danish project found no health concern for three exact peptides under the exposure studied; it did not clear the whole class |
| Myristoyl Pentapeptide-17 | Direct human eyelash evidence for the ingredient alone is not established here | Laboratory keratin results are not clinical eyelash outcomes | Included in the Danish three-peptide assessment; the conclusion is limited to its measured-use conditions |
| Panthenol and biotin | Cosmetic function evidence; not proven here to grow new eyelashes | Ingredient safety conclusions do not cover every eye-area formula | CIR assessed each under stated cosmetic uses and concentrations |
Frequently Asked Questions About Lash Serum Ingredients
What ingredient is proven to grow eyelashes?
Bimatoprost has an FDA-approved prescription indication for eyelash hypotrichosis. The claim is limited to the exact drug, dose, route, and use in its label. It does not prove that a cosmetic prostaglandin analogue, peptide, botanical, or conditioner has the same result.
Are peptide lash serums equal to bimatoprost?
No source reviewed for this hub establishes class-wide equivalence. The non-prostaglandin review describes limited formal evidence. A small open-label formula study cannot isolate one peptide or compare every peptide formula with prescription bimatoprost.
Does a high ingredient-list position prove a useful dose?
No. Position can help describe the list, but it cannot reveal the exact concentration or prove that the amount works. Do not treat the top part of a list, a preservative line, or one ingredient's position as a clinical dose test.
Does “prostaglandin-free” stay true forever?
No. A product formula can change. Check the full current label and keep the date and market where you found it. Our product guide is for shopping intent, while this hub explains ingredient evidence.
Is it safe to use a lash serum every day?
That depends on the exact product, ingredients, amount, directions, and person. An ingredient missing from our sources is not automatically safe. Stop use and seek medical advice for ongoing eye pain, redness, swelling, vision changes, or another concerning reaction. See our side-effects guide for more detail.
Continue your research:
- Lash serum ingredients to avoid: the chemical names, brands, and risks
- Best lash serums without prostaglandin: a product-comparison guide
- Lash serum side effects: source-linked risk information
- Best peptide lash serums: compare current product options
- Do lash serums really work?: understand formula-level evidence
- Castor oil vs. lash serum: conditioning versus growth claims
- Ingredient checker tool: identify covered names and flag anything not assessed